Albert DaCosta
Also at Paragon 28 Inc
About
Albert DaCosta is the co-founder and key executive driving FNA, having played a critical role in its formation and sustained growth since 2012. With over 18 years of experience in the foot and ankle industry, he laid the foundation for FNA’s evolution by leveraging his deep industry expertise and strategic vision.
Educated in Chemical Engineering with a minor in Business from the University of Florida, he has applied his technical knowledge and leadership skills to innovate within the medical device field. His early career included significant roles ranging from a sales representative to a distributor and even founding his own ventures, which helped shape his capabilities as a business leader.
Throughout his professional journey, his contributions have been instrumental in establishing a strong corporate culture and driving innovation, ensuring that FNA remains competitive in the highly specialized healthcare sector. His leadership not only underscores his dedication to excellence in this niche industry but also reflects his broader commitment to advancing healthcare solutions.
$FNA Performance Under Albert DaCosta
Past Roles
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Pioneer Surgical and Biomet Sports Medicine | Distributor | 2009-2010 | Worked as distributor for these companies |
| Wright Medical | Director of Biologics & Extremities | N/A [N/A] | Served in a director role |
| Body Beautiful Laser Centers | President & Founder | 2006 | Based in South Florida |
| Non-Invasive Solutions | President | 2005 | N/A [N/A] |
| Linvatec | Sales Representative | 2003 | N/A [N/A] |
Fixed Compensation
| Component Name | Amount (USD) | Payment Schedule | Additional Details |
|---|---|---|---|
| Salary | $700,769 | Annual | Fixed base salary |
| 401(k) Plan Contribution | $9,990 | Annual | 401(k) contribution |
| Executive Level Insurance Benefits (Medical, Life, and Disability) | $21,857 | Annual | Group insurance benefits |
Performance Compensation
Non-Equity Incentive Plan
| Metric Description | Value | Details/Conditions |
|---|---|---|
| Target Annual Cash Bonus Opportunity | 100% of base salary | Implies bonus target equals annualized base salary |
| Threshold Payout | $355,000 | Achieved at 50% of target if revenue objective met at threshold |
| Target Payout | $710,000 | Base target payout |
| Maximum Payout | $1,420,000 | Capped at 200% of target with maximum revenue and adjusted free cash flow achievement |
| Actual Bonus Award | $667,400 | Represents 94% of the target payout based on 2023 revenue achievement of $216.4 million |
| Performance Metrics | Revenue and Adjusted Free Cash Flow | Revenue threshold achieved partially; adjusted free cash flow goals not achieved |
| Evaluation Period | 2023 | Based on the 2023 Bonus Plan |
| Vesting Schedule | N/A (cash-based) | Cash incentive; no vesting required |
| Grant Date for Plan-Based Awards | February 28, 2023 | Establishes the period of performance measurement |
Stock Awards (Restricted Stock Units - RSUs)
| Metric Description | Value | Details/Conditions |
|---|---|---|
| Number of RSUs | 102,374 | Granted in 2023 |
| Grant Date | February 28, 2023 | Specific grant date provided |
| Grant Date Fair Value | $1,832,495 | Total fair value of the restricted stock units granted |
| Vesting Schedule | 25% each anniversary | 25% vest on the first anniversary; remaining vest at 25% per year over the subsequent three years |
| Performance Conditions | None | Awards are time-based with no performance metrics attached |
| Grant Date Stock Price | N/A | Stock price on grant date not provided |